Diabetes causes differential changes in CNS noradrenergic and dopaminergic neurons in the rat: A molecular study

Brain Research

Volumn 736, Issue 1-2, 1996, Pages 54-60

  Figlewicz, Dianne P ^a,b   Brot, Michelle D ^b   McCall, Anthony L ^c   Szot, Patricia ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

catecholamine; in situ hybridization; locus coeruleus; transporter; tyrosine hydroxylase; ventral tegmental area

Indexed keywords

MESSENGER RNA; STREPTOZOCIN; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DOPAMINERGIC NERVE CELL; IN SITU HYBRIDIZATION; LOCUS CERULEUS; MALE; NEUROTRANSMITTER UPTAKE; NONHUMAN; NORADRENERGIC NERVE; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA; VENTRAL TEGMENTUM;

EID: 0030583628     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-8993(96)00727-5     Document Type: Article

References (41)

1. [1] Ahmad, Q. and Merali, Z., Diabetic rats display blunted behavioral response to d-amphetamine or dark phase: implications of altered dopamine (DA) function, Soc. Neurosci. Abstr., 18 (1992) 1071.
2. [2] Amara, S.G. and Kuhar, M.J., Neurotransmitter transporters: recent progress, Ann. Rev. Neurosci., 16 (1993) 73-93.
3. [3] Bellush, L.L. and Reid, S.G., Altered behavior and neurochemistry during short-term insulin withdrawal in streptozotocin-induced diabetic rats. Diabetes, 40 (1991) 217-222.
4. [4] Cerruti, C., Pilotte, N.S., Uhl, G. and Kuhar, M.J., Reduction in dopamine transporter mRNA after cessation of repeated cocaine administration, Mol. Brain Res., 22 (1994) 132-138.
5. [5] Chu, P.C., Lin, M.T., Shian, L.R. and Leu, S.Y., Alterations in physiologic functions and in brain monoamine content in streptozotocin-diabetic rats, Diabetes, 35 (1986) 481-485.
6. [6] Claye, L.H., Akunne, H.C., Davis, M.D., DeMattos, S. and Soliman, K.F.A., Behavioral and neurochemical changes in the dopaminergic system after repeated cocaine administration. Mol. Neurobiol., 11 (1995) 55-66.
7. [7] Corey, J.L., Davidson, N., Lester, H.A., Brecha, N. and Quick, M.W., Protein kinase C modulates the activity of a cloned γ-aminobutyric acid transporter expressed in Xenopus oocytes via regulated subcellular redistribution of the transporter, J. Biol. Chem., 269 (1994) 14759-14767.
8. [8] Czech, M.P., Molecular actions of insulin on glucose transport, Ann. Rev. Nutrition, 15 (1995) 441-471.
9. [9] Figlewicz, D.P., Dorsa, D., Ikeda, H., Stein, L.J., Baskin, D. and Woods, S.C., Brain insulin binding and content are altered by streptozotocin treatment in rats, Diabetes, 32 (Suppl 1) (1983) 134A.
10. [10] Figlewicz, D.P., Szot, P., Chavez, M., Woods, S.C. and Veith, R.C., Intraventricular insulin increases dopamine transporter mRNA in rat VTA/substantia nigra, Brain Res., 644 (1994) 331-334.
11. [11] Figlewicz, D.P., Szot, P., Israel, P.A., Payne, C. and Dorsa, D.M., Insulin reduces norepinephrine transporter mRNA in vivo in rat locus coeruleus. Brain Res., 602 (1993) 161-164.
12. [12] Figlewicz Lattemann, D. and Szot, P., Metabolic regulation of the CNS dopamine transporter (DAT), Appetite, 23 (1994) 301.
13. [13] Ganzini, L., Casey, D.E., Hoffman, W.F. and McCall, A.L., The prevalence of metoclopramide-induced tardive dyskinesia and acute extrapyramidal movement disorders, Arch. Intern. Med., 153 (1993) 1469-1475.
14. [14] Ganzini, L., Heintz, R.T., Hoffman, W.F. and Casey, D.E., The prevalence of tardive in neuroleptic-treated diabetics, Arch. Gen. Psychiatry, 48 (1991) 259-263.
15. [15] Glanville, N.T. and Anderson, G.H., Hypothalamic catecholamine metabolism in diabetic rats: the effect of insulin deficiency and meal ingestion, J. Neurochem., 46 (1986) 753-759.
16. [16] Goldstein, M., Long-and short-term regulation of tyrosine hydroxylase. In F.E. Bloom and D.J. Kupfer (Eds.), Psychopharmacology: The Fourth Generation of Progress, Raven Press, New York, 1995.
17. [17] Heaton, J.P.W. and Varrin, S.J., Effects of streptozotocin-induced diabetes on dopaminergic functioning in the rat: analysis of yawning behavior, Pharm. Biochem. Behav., 44 (1993) 601-604.
18. [18] Kilbourne, E.J., Nankova, B.B., Lewis, E.J., McMahon, A., Osaka, H., Sabban, D.B. and Sabban, E.L., Regulation of the expression of the tyrosine hydroxylase gene by membrane depolarization: identification of the responsive element and possible second messengers, J. Biol. Chem., 267 (1992) 7563-7569.
19. [19] Kono, T. and Takada, M., Dopamine depletion in nigrostriatal neurons in the genetically diabetic rat, Brain Res., 634 (1994) 155-158.
20. [20] Leedom, L.J. and Meehan, W.P., The psychoneuroendocrinology of diabetes mellitus in rodents, Psychoneuroendocrinology, 14 (1989) 275-294.
21. [21] Liao, K. and Lane, M.D., Expression of a novel insulin-activated amino acid transporter gene during differentiation of 3T2-L1 preadipocytes into adipocytes, Biochem. Biophys. Res. Comm., 208 (1995) 1008-1015.
22. 3H]WIN 35428 binding sites in human striatum, Brain Res., 628 (1993) 17-25.
23. [23] Liaw, J.-J., He, J.-R. and Barraclough, C.A., Temporal changes in tyrosine hydroxylase mRNA levels in A1, A2 and locus ceruleus neurons following electrical stimulation of A1 noradrenergic neurons, Mol. Brain Res., 13 (1992) 171-174.
24. [24] Lozovsky, D., Saller, C.F. and Kopin, I.J., Dopamine receptor binding is increased in diabetic rats, Science, 214 (1981) 1031-1033.
25. [25] Lustman, P.J., Anxiety disorders in adults with diabetes mellitus, Psychiatt. Clin. N. Am., 11 (1988) 419-432.
26. [26] Max, M.B., Lynch, S.A., Muir, J., Shoaf, S.E., Smoller, B. and Dubner, R., Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy, N. Engl. J. Med., 326 (1992) 1250-1256.
27. [27] McCall, A.L., The impact of diabetes on the CNS, Diabetes, 41 (1992) 557-570.
28. [28] Pilotte, N.S., Sharpe, L.G. and Kuhar, M.J., Withdrawal of repeated intravenous infusions of cocaine persistently reduces binding to dopamine transporters in the nucleus accumbens of Lewis rats, J. Pharm. Exp. Ther., 269 (1994) 963-969.
29. [29] Ramamoorthy, S., Cool, D.R., Mahesh, V.B., Leibach, F.H., Melikian, H.E., Blakely, R.D. and Ganapathy, V., Regulation of the human serotonin transporter. Cholera toxin-induced stimulation of serotonin uptake in human placental choriocarcinoma cells is accompanied by increased serotonin transporter mRNA levels and serotonin transporter-specific ligand binding. J. Biol. Chem., 268 (1993) 21626-21631.
30. [30] Saller, C.F. and Chiodo, L.A., Glucose suppresses basal firing and haloperidol-induced increases in the firing rate of central dopaminergic neurons. Science, 210 (1980) 1269-1271.
31. [31] Shimizu, H., Alteration in hypothalamic monoamine metabolism of freely moving diabetic rat, Neurosci. Lett., 131 (1991) 225-227.
32. [32] Shimomura, Y., Shimizu, H., Takahashi, M., Uehara, Y., Kobayashi, I. and Kobayashi, S., Ambulatory activity and dopamine turnover in streptozotocin-induced diabetic rats, Exp. Clin. Endocrinol., 95 (1990) 385-388.
33. [33] Shores, M.M., Szot, P. and Veith, R.C., Desipramine-induced increase in norepinephrine transporter mRNA is not mediated via α2 receptors, Mol. Brain Res., 27 (1994) 337-341.
34. [34] Simantov, R., Chronic morphine alters dopamine transporter density in the rat brain: possible role in the mechanism of drug addiction, Neurosci. Lett., 163 (1993) 121-124.
35. [35] Stephens, J.M. and Pilch, P.F., The metabolic regulation and vesicular transport of GLUT4, the major insulin-responsive glucose transporter, Endocrinol. Rev., 16 (1995) 529-546.
36. [36] Szot, P., Ashleigh, E.A., Kohen, R., Petrie, E., Dorsa, D.M. and Veith, R., Norepinephrine transporter mRNA is elevated in the locus coeruleus following short-and long-term desipramine treatment, Brain Res., 618 (1993) 308-312.
37. [37] Szot, P. and Veith, R.C., Effect of pentylenetetrazol on the expression of tyrosine hydroxylase mRNA and norepinephrine and dopamine transporter mRNA, Mol. Brain Res., in press.
38. [38] Tejani-Butt, S.M. and Yang, J., A time course of altered thyroid states on the noradrenergic system in rat brain by quantitative autoradiography, Neuroendocrinology, 59 (1994) 235-244.
39. 3H]spiroperidol binding in streptozotocin-diabetic rats, J. Neurochem., 40 (1983) 1456-1459.
40. [40] Weyerer, S., Hewer, W., Pfeifer-Kurda, M. and Dilling, H., Psychiatric disorders and diabetes-results from a community study, J. Psychosomat. Res., 33 (1989) 633-640.
41. [41] Worrall, D.M. and Williams, D.C., Sodium ion-dependent transporters for neurotransmitters: a review of recent developments, Biochem. J., 297 (1994) 425-436.